Zdrowie i gospodarka · 28/01/2013
FDA Releases Guidance on Clinical Pharmacogenomics for Pharmaceutical Industry
The Food and Drug Administration (FDA) has published a guidance document to help the pharmaceutical industry and researchers evaluate the impact of genetic variations on drug development, efficacy, and safety.
Source: Federal Register — Food and Drug AdministrationOpen original release →